Michael Schmidt
Stock Analyst at Guggenheim
(4.92)
# 209
Out of 4,407 analysts
469
Total ratings
53.4%
Success rate
28.1%
Average return
Main Sectors:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics | Maintained: Buy | $80 | $46.13 | +73.42% | 2 | Jun 12, 2026 | |
| TNGX Tango Therapeutics | Maintained: Buy | $32 | $30.94 | +3.43% | 11 | Jun 9, 2026 | |
| INCY Incyte | Maintained: Buy | $130 | $108.53 | +19.78% | 40 | Jun 8, 2026 | |
| ADCT ADC Therapeutics | Maintained: Buy | $10 | $1.05 | +852.38% | 14 | Jun 5, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $420 | $264.48 | +58.80% | 22 | Jun 3, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $205 | $153.87 | +33.23% | 19 | Jun 1, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 | $30.54 | +47.35% | 10 | Jun 1, 2026 | |
| GMAB Genmab | Maintained: Buy | $40 | $25.06 | +59.65% | 11 | May 25, 2026 | |
| IMNM Immunome | Maintained: Buy | $35 | $18.38 | +90.42% | 6 | May 12, 2026 | |
| VSTM Verastem | Maintained: Buy | $14 | $4.10 | +241.46% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $3.01 | +398.34% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.62 | - | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.00 | +200.00% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $33.10 | +35.95% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $35.27 | +2.08% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $10 | $3.75 | +166.67% | 12 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $30 | $18.24 | +64.52% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $20 | $14.05 | +42.35% | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.18 | +187.08% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $53.13 | - | 43 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $29.72 | +7.67% | 4 | Feb 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $86.21 | -30.40% | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $12 | $2.03 | +491.13% | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $14.81 | -32.48% | 5 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $7.58 | +97.89% | 14 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0315 | - | 15 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.41 | n/a | 3 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.96 | n/a | 9 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.08 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $35.87 | n/a | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $28.97 | n/a | 2 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1,617.64 | n/a | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.56 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.19 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.90 | n/a | 6 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.04 | n/a | 4 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.31 | n/a | 7 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $43 | $18.25 | n/a | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 | $8.05 | n/a | 6 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $8.27 | n/a | 3 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.06 | n/a | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.09 | n/a | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $63 | $29.46 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $355.20 | n/a | 2 | Sep 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 | $12.33 | n/a | 13 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.10 | n/a | 2 | Jun 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $140 → $85 | $7.33 | n/a | 5 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $19 | $17.56 | n/a | 1 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.56 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $27.57 | n/a | 10 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $15 | $2.02 | n/a | 5 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $4.26 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $0.0001 | n/a | 6 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $73.28 | n/a | 9 | Oct 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $282.85 | n/a | 12 | Oct 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $1.5 | $0.74 | n/a | 5 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $9.50 | n/a | 8 | Sep 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.11 | n/a | 3 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.87 | n/a | 3 | Aug 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.28 | n/a | 4 | Oct 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $177 → $181 | $230.56 | n/a | 5 | Aug 6, 2014 |
Enliven Therapeutics
Jun 12, 2026
Maintained: Buy
Price Target: $80
Current: $46.13
Upside: +73.42%
Tango Therapeutics
Jun 9, 2026
Maintained: Buy
Price Target: $32
Current: $30.94
Upside: +3.43%
Incyte
Jun 8, 2026
Maintained: Buy
Price Target: $130
Current: $108.53
Upside: +19.78%
ADC Therapeutics
Jun 5, 2026
Maintained: Buy
Price Target: $10
Current: $1.05
Upside: +852.38%
BeOne Medicines AG
Jun 3, 2026
Maintained: Buy
Price Target: $420
Current: $264.48
Upside: +58.80%
Revolution Medicines
Jun 1, 2026
Maintained: Buy
Price Target: $205
Current: $153.87
Upside: +33.23%
ArriVent BioPharma
Jun 1, 2026
Maintained: Buy
Price Target: $45
Current: $30.54
Upside: +47.35%
Genmab
May 25, 2026
Maintained: Buy
Price Target: $40
Current: $25.06
Upside: +59.65%
Immunome
May 12, 2026
Maintained: Buy
Price Target: $35
Current: $18.38
Upside: +90.42%
Verastem
May 7, 2026
Maintained: Buy
Price Target: $14
Current: $4.10
Upside: +241.46%
May 7, 2026
Maintained: Buy
Price Target: $15
Current: $3.01
Upside: +398.34%
May 7, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.62
Upside: -
May 6, 2026
Maintained: Buy
Price Target: $12
Current: $4.00
Upside: +200.00%
May 6, 2026
Maintained: Buy
Price Target: $45
Current: $33.10
Upside: +35.95%
May 5, 2026
Reiterated: Buy
Price Target: $36
Current: $35.27
Upside: +2.08%
Apr 10, 2026
Maintained: Buy
Price Target: $6 → $10
Current: $3.75
Upside: +166.67%
Mar 18, 2026
Maintained: Buy
Price Target: $34 → $30
Current: $18.24
Upside: +64.52%
Mar 13, 2026
Maintained: Buy
Price Target: $12 → $20
Current: $14.05
Upside: +42.35%
Mar 11, 2026
Maintained: Buy
Price Target: $12
Current: $4.18
Upside: +187.08%
Feb 10, 2026
Maintained: Hold
Price Target: n/a
Current: $53.13
Upside: -
Feb 1, 2026
Maintained: Buy
Price Target: $32
Current: $29.72
Upside: +7.67%
Aug 11, 2025
Maintained: Buy
Price Target: $60
Current: $86.21
Upside: -30.40%
Aug 11, 2025
Maintained: Buy
Price Target: $10 → $12
Current: $2.03
Upside: +491.13%
Aug 7, 2025
Maintained: Buy
Price Target: $10
Current: $14.81
Upside: -32.48%
Aug 6, 2025
Maintained: Buy
Price Target: $16 → $15
Current: $7.58
Upside: +97.89%
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0315
Upside: -
May 27, 2025
Maintained: Hold
Price Target: n/a
Current: $1.41
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $3.96
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $4.08
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $35.87
Upside: n/a
Oct 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $28.97
Upside: n/a
Jun 27, 2024
Maintained: Hold
Price Target: n/a
Current: $1,617.64
Upside: n/a
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.56
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.19
Upside: n/a
Jan 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.90
Upside: n/a
Dec 20, 2023
Rated: Hold
Price Target: n/a
Current: $2.04
Upside: n/a
Dec 7, 2023
Maintained: Buy
Price Target: n/a
Current: $8.31
Upside: n/a
Oct 3, 2023
Maintained: Buy
Price Target: $40 → $43
Current: $18.25
Upside: n/a
Jun 27, 2023
Downgraded: Hold
Price Target: $20
Current: $8.05
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $15
Current: $8.27
Upside: n/a
Jan 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $2.06
Upside: n/a
Apr 28, 2021
Downgraded: Hold
Price Target: n/a
Current: $3.09
Upside: n/a
Feb 25, 2021
Maintained: Buy
Price Target: $66 → $63
Current: $29.46
Upside: n/a
Sep 18, 2020
Maintained: Hold
Price Target: n/a
Current: $355.20
Upside: n/a
Aug 6, 2020
Maintained: Buy
Price Target: $44
Current: $12.33
Upside: n/a
Jun 23, 2020
Maintained: Buy
Price Target: n/a
Current: $29.10
Upside: n/a
Sep 17, 2018
Initiated Coverage: Buy
Price Target: $140 → $85
Current: $7.33
Upside: n/a
May 8, 2017
Initiated Coverage: Hold
Price Target: $19
Current: $17.56
Upside: n/a
Nov 30, 2016
Maintained: Buy
Price Target: n/a
Current: $1.56
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $27 → $23
Current: $27.57
Upside: n/a
Nov 11, 2016
Reiterated: Hold
Price Target: $1.5 → $15
Current: $2.02
Upside: n/a
Nov 10, 2016
Reiterated: Hold
Price Target: $5
Current: $4.26
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $3 → $2
Current: $0.0001
Upside: n/a
Oct 9, 2016
Reiterated: Hold
Price Target: $36
Current: $73.28
Upside: n/a
Oct 5, 2016
Reiterated: Hold
Price Target: $40
Current: $282.85
Upside: n/a
Sep 20, 2016
Reiterated: Hold
Price Target: $4 → $1.5
Current: $0.74
Upside: n/a
Sep 6, 2016
Reiterated: Buy
Price Target: $18
Current: $9.50
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: n/a
Current: $12.11
Upside: n/a
Aug 16, 2016
Reiterated: Buy
Price Target: $28
Current: $5.87
Upside: n/a
Oct 6, 2015
Reiterated: Buy
Price Target: n/a
Current: $44.28
Upside: n/a
Aug 6, 2014
Rated: Buy
Price Target: $177 → $181
Current: $230.56
Upside: n/a